Establishment of C.elegans tissue culture cell lines
线虫组织培养细胞系的建立
基本信息
- 批准号:7022444
- 负责人:
- 金额:$ 18.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-01 至 2008-01-31
- 项目状态:已结题
- 来源:
- 关键词:Caenorhabditis elegansRNA interferenceallelesbiological modelsbiological signal transductionbiomarkercell adhesioncell differentiationcell growth regulationcell linecell proliferationdensityembryonic stem cellgene expressiongene mutationgenetic modelsgerm cellsgonadsgrowth mediakaryotypeligandsmeiosismodel design /developmenttelomerasetissue /cell culture
项目摘要
DESCRIPTION (provided by applicant): The nematode C. elegans is a powerful molecular genetic system that has been used to address fundamental questions of cell, molecular, and developmental biology. Currently, there are no C. elegans tissue culture cell lines. C. elegans cell lines would allow a number of experimental approaches that are currently unavailable, including: biochemistry with homogenous cell populations; cell cycle synchronization for molecular analysis in specific cell cycle stages; studies of in vitro differentiation; large-scale RNAi screens for cell autonomous defects; and small molecule inhibitor screens. Additionally, a germ cell line would provide a foundation for targeted gene replacement. There are two major impediments that have historically blocked the creation of C. elegans cell lines. First, all C. elegans somatic cells undergo developmentally- programmed cell cycle arrest. Second, germ cells in the animal are syncytial and cannot be isolated as individual cells. The use of specific genetic backgrounds has allowed us to overcome both of these initial obstacles. This proposal is focused on addressing the remaining impediments to the creation of cell lines: embryonic cells must be maintained in a proliferative state without differentiating, as differentiation removes cells from the proliferative pool; and germ cells must be induced to divide in culture. A number of approaches will be used to attain cell lines, including optimizing the culture media (such as the use of C. elegans extract and cell feeder systems), defining the proper cell density for culturing, and identifying cell attachment conditions. Different mutant backgrounds will be used to increase proliferation and/or limit differentiation. Telomerase will be expressed in embryonic cells to counter potential telomere shortening- induced cell cycle arrest. Recombinant GLP-1 ligand will be provided to germ cells in culture to block meiotic entry. Alternatively, germ cells will be derived from mutant backgrounds that are constitutively active for the GLP-1 signaling pathway, and therefore never enter meiosis. Cells will be characterized for differentiation markers, karyotype, and RNAi capability. The nematode C. elegans has provided breakthroughs in the understanding of cell death, developmental biology, the cell cycle, and signal transduction that have had important implications for cancer and human genetic diseases. The availability of cell lines would greatly extend research using this organism to provide further health-related insights.
描述(申请人提供):线虫C.线虫是一种强大的分子遗传系统,已被用于解决细胞、分子和发育生物学的基本问题。目前没有C。线虫组织培养细胞系。C. elegans细胞系将允许许多目前不可用的实验方法,包括:同质细胞群的生物化学;用于特定细胞周期阶段的分子分析的细胞周期同步化;体外分化研究;细胞自主缺陷的大规模RNAi筛选;以及小分子抑制剂筛选。此外,生殖细胞系将为靶向基因替代提供基础。历史上有两个主要的障碍阻碍了C语言的创建。elegans细胞系。首先,所有C。线虫体细胞经历发育程序性细胞周期停滞。第二,动物的生殖细胞是合胞体,不能分离为单个细胞。使用特定的遗传背景使我们能够克服这两个最初的障碍。该提议的重点是解决创建细胞系的剩余障碍:胚胎细胞必须保持在增殖状态而不分化,因为分化将细胞从增殖池中移除;并且必须诱导生殖细胞在培养中分裂。许多方法将用于获得细胞系,包括优化培养基(如使用C。elegans提取物和细胞饲养系统),确定用于培养的适当细胞密度,并鉴定细胞附着条件。不同的突变体背景将用于增加增殖和/或限制分化。端粒酶将在胚胎细胞中表达以对抗潜在的端粒缩短诱导的细胞周期停滞。将向培养的生殖细胞提供重组GLP-1配体,以阻断减数分裂进入。或者,生殖细胞将源自对GLP-1信号通路具有组成性活性的突变背景,因此永远不会进入减数分裂。将表征细胞的分化标志物、核型和RNAi能力。线虫C.线虫在细胞死亡、发育生物学、细胞周期和信号转导等方面的研究取得了突破性进展,这些研究对癌症和人类遗传疾病具有重要意义。细胞系的可用性将大大扩展使用这种生物体的研究,以提供进一步的健康相关见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD T. KIPREOS其他文献
EDWARD T. KIPREOS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD T. KIPREOS', 18)}}的其他基金
Cell cycle regulation by C. elegans CUL-2 E3 complexes
线虫 CUL-2 E3 复合物的细胞周期调节
- 批准号:
7904460 - 财政年份:2009
- 资助金额:
$ 18.4万 - 项目类别:
Cell cycle regulation by C. elegans CUL-2 E3 complexes
线虫 CUL-2 E3 复合物的细胞周期调节
- 批准号:
7199405 - 财政年份:2007
- 资助金额:
$ 18.4万 - 项目类别:
Cell cycle regulation by C. elegans CUL-2 E3 complexes
线虫 CUL-2 E3 复合物的细胞周期调节
- 批准号:
7570108 - 财政年份:2007
- 资助金额:
$ 18.4万 - 项目类别:
Cell cycle regulation by C. elegans CUL-2 E3 complexes
线虫 CUL-2 E3 复合物的细胞周期调节
- 批准号:
7755850 - 财政年份:2007
- 资助金额:
$ 18.4万 - 项目类别:
Regulation of the cell cycle and signaling by CUL-2 E3 complexes
CUL-2 E3 复合物对细胞周期和信号传导的调节
- 批准号:
8515451 - 财政年份:2007
- 资助金额:
$ 18.4万 - 项目类别:
Cell cycle regulation by C. elegans CUL-2 E3 complexes
线虫 CUL-2 E3 复合物的细胞周期调节
- 批准号:
7339890 - 财政年份:2007
- 资助金额:
$ 18.4万 - 项目类别:
Regulation of the cell cycle and signaling by CUL-2 E3 complexes
CUL-2 E3 复合物对细胞周期和信号传导的调节
- 批准号:
8633464 - 财政年份:2007
- 资助金额:
$ 18.4万 - 项目类别:
相似海外基金
Investigation of improvement of skeletal muscle function by RNA interference for prevention of frailty
通过 RNA 干扰改善骨骼肌功能预防衰弱的研究
- 批准号:
23K10830 - 财政年份:2023
- 资助金额:
$ 18.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
- 批准号:
10539405 - 财政年份:2022
- 资助金额:
$ 18.4万 - 项目类别:
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
- 批准号:
10688080 - 财政年份:2022
- 资助金额:
$ 18.4万 - 项目类别:
Using RNA interference to combat the worst emerging disease of wildlife
利用 RNA 干扰对抗野生动物最严重的新疾病
- 批准号:
DP220101361 - 财政年份:2022
- 资助金额:
$ 18.4万 - 项目类别:
Discovery Projects
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
- 批准号:
10677770 - 财政年份:2022
- 资助金额:
$ 18.4万 - 项目类别:
Regulation of RNA interference pathways by extracellular cues
细胞外信号对 RNA 干扰途径的调节
- 批准号:
RGPIN-2019-04411 - 财政年份:2022
- 资助金额:
$ 18.4万 - 项目类别:
Discovery Grants Program - Individual
CAREER: Investigating the Role of an RNA Interference Pathway in Safeguarding the Tetrahymena Thermophila Somatic Genome
职业:研究 RNA 干扰途径在保护嗜热四膜虫体细胞基因组中的作用
- 批准号:
2143019 - 财政年份:2022
- 资助金额:
$ 18.4万 - 项目类别:
Continuing Grant
New Cancer Therapy: A Combination of RNA Interference and Gene Therapy
新的癌症疗法:RNA干扰和基因疗法的结合
- 批准号:
486535 - 财政年份:2022
- 资助金额:
$ 18.4万 - 项目类别:
Studentship Programs
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
- 批准号:
10330828 - 财政年份:2022
- 资助金额:
$ 18.4万 - 项目类别:
CAREER: Abiotic degradation of emerging RNA interference pesticides
职业:新兴 RNA 干扰农药的非生物降解
- 批准号:
2046602 - 财政年份:2021
- 资助金额:
$ 18.4万 - 项目类别:
Continuing Grant